Guidelines from the National Institute for Health and Care Excellence recommend Novartis' Cosentyx for treating active ankylosing spondylitis that has not responded well enough to conventional therapy.
29th September 2016
NHS Improvement is placing the South East Coast Ambulance Service NHS Foundation Trust into Special Measures on the back of a series of concerns that came to light in its latest Care Quality Commission (CQC) inspection report.
29th September 2016
Clinical Commissioning Groups are being given an extra £25 million by NHS England to accelerate plans for improving mental health services for children and young people.
28th September 2016
Coventry, UK-based University of Warwick spin-out Medherant has secured funding of £1.5 million to fuel further development of its novel drug patch delivery technology.
28th September 2016
Cost regulators have now published final guidance endorsing routine NHS use of Bayer's Eylea for all patients with visual impairment due to branch retinal vein occlusion (BRVO), having initially recommended its use only in the second-line setting.
28th September 2016
Bristol-Myers Squibb has signed a clinical trials pact with Nektar Therapeutics that will test a combination of the firms' immunotherapy drugs across a range of cancer indications.
28th September 2016
Shire has handed back rights to the two biosimilars it acquired through its recent purchase of Baxalta, retaining its focus on the development of drugs for rare diseases.
28th September 2016
US regulators have expanded the reach of Johnson & Johnson group Janssen Biologics' psoriasis blockbuster Stelara to include the treatment of patients with Crohn's disease.
27th September 2016
GW Pharmaceuticals has unveiled yet more positive data from a late-stage programme testing its cannabinoid Epidiolex in rare epilepsies, pushing its stock up more than 16 percent.
27th September 2016
Novartis has picked up three new indications for its anti-inflammatory Ilaris in the US, allowing its use to treat three rare and distinct types of Periodic Fever Syndromes.
27th September 2016
The British Medical Association has called off further industrial action in protest over the new junior doctors contract on fears over patient safety.
27th September 2016
MSD and Wayra UK have unveiled the next focus of their digital health innovation accelerator programme, calling for "radical solutions" to improving the treatment and care of patients with diabetes and helping cancer patients self-manage recovery.
27th September 2016
GlaxoSmithKline has filed for approval of a subcutaneous formulation of its lupus drug Benlysta on both sides of the Atlantic.
26th September 2016
The National Institute for Health and Care Excellence is endorsing Gilead's pan-genotypic hepatitis C drug Epclusa for routine NHS use in England and Wales.
26th September 2016
NHS England investment fund SBRI Healthcare has launched its autumn competition offering entrepreneurs the opportunity for funding to drive forward their innovations within general practice.
26th September 2016
What job are you looking for?
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
